Scanning and combinatorial library services – Save 20% with code TRY-BXPLIB-20

Video Resources

thumb-david-webinar

Unlocking the Potential of mRNA as a Tool for Immuno-Oncology Therapy Discovery and Development

Discover the latest in immuno-oncology: Overcoming traditional TCR gene expression limits using mRNA for rapid, cost-effective candidate screening. Learn how automation in synthetic biology enhances adoptive T-cell therapies and vaccine discovery.

Watch now
thumb-jazzy-webinar

Accelerating antibody discovery with cell-free DNA synthesis

In this webinar brought to you by Telesis Bio, Jasmine Hershewe will discuss a cell-free platform that automates DNA printing, cloning, and amplification, expediting the screening and identification of lead antibody candidates.

Watch now
thumb-genome-engineering

Enabling on-demand synthesis of genome engineering tools at the push of a button

Tune into this on-demand webinar for an exploration of Telesis Bio's innovative BioXp® platform and SOLA DNA synthesis technology. Learn how these tools are redefining the landscape of synthetic and molecular biology, accelerating the pace of discovery and therapeutic development.

Watch now
thumb-synthesis-kit

mRNA's Untapped Potential: How to Engineer and Optimize Design for Immunotherapy

Watch this on-demand webinar to gain in-depth knowledge about the mRNA synthesis solutions powered by the BioXp, including the differences and applications of mRNA De novo and mRNA Select Synthesis kits.

Watch now
9600 thumbnail

The BioXp® system: Accelerating hit-to-lead discovery by breaking through critical synthesis bottlenecks

In this presentation, learn how Telesis Bio’s automated BioXp synthetic biology solutions are designed to help you break free from traditional lead synthesis bottlenecks and significantly accelerate your antibody discovery pipeline.

Watch now
img-webinar-resources-streamlining-molecular-biology

Streamlining molecular biology workflows throughout biologics discovery

Join us for our recorded webinar presented at SynBiobeta 2023 to explore Telesis Bio's BioXp platform for automating molecular biology workflows in synthetic biology and multiomic applications.

Watch now
img-webinar-resources-beyond-covid

Beyond Covid: Leveraging synthetic biology to advance the potential of mrna -bassed vaccines

Join us for our recorded webinar presented at SynBioBeta 2023 to explore the groundbreaking potential of synthetic biology in advancing mRNA-based vaccines. Discover how Telesis Bio addresses the bottlenecks in vaccine discovery.

Watch now
video resources

Sequence in, mRNA out. A new paradigm to accelerate discovery of mRNA Vaccines and theraputics

Long lead times for mRNA synthesis can create a bottleneck to advancing discovery and maximizing the potential of mRNA-based vaccines and therapeutics. In this presentation, Dr. Kannan highlights the challenges of current mRNA synthesis workflows...

Watch now
video resources

Engineering and Results of Next-Generation COVID-19 Vaccines

In this talk sponsored by Telesis Bio, Dr. David Brown, Associate Director, R&D at RNAimmune presents an intro into the key technology, tools and knowhow driving their mRNA vaccine development programs. He describes how their team utilized the BioXp® system....

Watch now
video resources

Harnessing the power of synthetic biology to combat COVID-19

Learn how Dr. Dan Gibson and team approached completing the world’s first on-demand synthesis of the SARS-CoV-2 genome — the causal agent of COVID-19 — using a commercially available, automated DNA assembly and cloning instrument — the BioXp™ system...

Watch now
video resources

Optimizing Production Workflows with the BioXp System: Overcoming Process Bottlenecks Utilizing Automated Synthetic Biology Solustions

In an industry facing increasingly challenging deliverables, the ability to rapidly build synthetic DNA, mRNA, and protein is critical. Imagine an antibody development pipeline...

Watch now
video resources

Targeting Kras mutations in cancer: new mRNA vaccines on the horizon

In this video, Dr. Shen, discusses the application of the BioXp technology that was key to accelerating RNAimmune’s vaccine discovery process for the KRAS vaccine. The presentation is focused on RNAimmune’s cancer vaccine discovery platform...

Watch now
video resources

Synthetic Biology and Coronavirus: Preventing Future pandemics

In this webinar, speakers Dr. Krishna Kannan and Dr. Silvi Rouskin bring decades of experience in synthetic biology and viral research, blending the 2 topics in a seamless way...

Watch now
video resources

Rethink mRNA-based Discovery Workflows with the Power of Automated Synthetic Biology

The success of mRNA-based COVID-19 vaccines has resulted in increased opportunity for advancing mRNA as a platform for vaccine and therapeutic discovery...

Watch now
video resources

Building Biology Overnight: Eliminating Synthesis Bottlenecks with Hands-Free Automated Synthetic Biology Solutions

If your discovery program is limited by the speed of your capabilities in synthesis and cloning of lead candidates, you’re not alone. Learn how Telesis Bio’s hands-free automated BioXp® synthetic biology solutions...

Watch now
video resources

Overcoming Process Bottlenecks in Antibody Discovery through End-to-End Automated Synthetic Biology Solutions

In this presentation, you will learn how to construct synthesis is a bottleneck in antibody therapeutic development...

Watch now
video resources

Synthetic Biology Solutions to Optimize Metabolic Pathway Engineering Workflows

In this webinar, Dr. Elisa Marques from Telesis Bio will provide an overview of the latest synthetic biology solutions for metabolic pathway and enzyme engineering and how these can be used to improve discovery processes...

Watch now